Ahmed, N. and Thornalley, P. J. (2007). Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes, Obesity and Metabolism, 9, 233–245.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.
Andersen, C. K., Wittrup-Jensen, K. U., Lolk, A., Andersen, K. and Kragh-Sørensen, P. (2004). Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health and Quality of Life Outcomes, 2, 52.
Avery, N. C. and Bailey, A. J. (2005). Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scandinavian Journal of Medicine & Science in Sports, 15, 231–240.
Bird, T. D. (1993). Alzheimer Disease Overview. In Pagon, R. A.
et al. (eds.). Seattle, WA: GeneReviews [Internet].
Buchman, A. S. and Bennett, D. A. (2011). Loss of motor function in preclinical Alzheimer's disease. Expert Review of Neurotherapeutics, 11, 665–676.
Collin, C., Wade, D. T., Davies, S. and Horne, V. (1988). The Barthel ADL Index: a reliability study. International Disability Studies, 10, 61–63.
Drenth, H., Zuidema, S., Krijnen, W., Bautmans, I., van der Schans, C. and Hobbelen, H. (2017). Advanced glycation end-products are associated with the presence and severity of paratonia in early stage Alzheimer's disease. Journal of the American Medical Directors Association, in press.
Drenth, H., Zuidema, S., Bunt, S., Bautmans, I., van der Schans, C. and Hobbelen, H. (2016). The contribution of advanced glycation end product (AGE) accumulation to the decline in motor function. European Review of Aging and Physical Activity: Official Journal of the European Group for Research into Elderly and Physical Activity, 13, 3.
Farmer, S. E. and James, M. (2001). Contractures in orthopaedic and neurological conditions: a review of causes and treatment. Disability and Rehabilitation, 23, 549–558.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Giebel, C. M., Sutcliffe, C. and Challis, D. (2017). Hierarchical decline of the initiative and performance of complex activities of daily living in dementia. Journal of Geriatric Psychiatry and Neurology, 30, 96–103.
Graham, J. E., Ostir, G. V., Fisher, S. R. and Ottenbacher, K. J. (2008). Assessing walking speed in clinical research: a systematic review. Journal of Evaluation in Clinical Practice, 14, 552–562.
Hobbelen, J. S. M., Koopmans, R.T., Verhey, F. R., Habraken, K. M. and de Bie, R. A. (2008). Diagnosing paratonia in the demented elderly: reliability and validity of the paratonia assessment instrument (PAI). International Psychogeriatrics/IPA, 20, 840–852.
Kempen, G. I. J. M. and Doeglas, D. M. and Suurmeijer, Th. P. B. M. (1993). Het Meten Van Problemen met Zelfredzaamheid op Verzorgend en Huishoudelijk Gebied met de GARS: Een Handleiding. 1st edn., Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, Rijksuniversiteit Groningen.
Li, J., Liu, D., Sun, L., Lu, Y. and Zhang, Z. (2012). Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. Journal of the Neurological Sciences, 317, 1–5.
Liu, G. and Liang, K. Y. (1997). Sample size calculations for studies with correlated observations. Biometrics, 53, 937–947.
Magelhaes, P.M., Appell, H. J. and Duarte, J. A. (2008). Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity. European Review of Aging and Physical Activity, 5, 17–29.
Martyr, A. and Clare, L. (2012). Executive function and activities of daily living in Alzheimer's disease: a correlational meta-analysis. Dementia and Geriatric Cognitive Disorders, 33, 189–203.
et al. (2004). Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia, 47, 1324–1330.
Metzelthin, S. F.
et al. (2010). The psychometric properties of three self-report screening instruments for identifying frail older people in the community. BMC Public Health, 10, 176.
Nenna, A., Spadaccio, C., Lusini, M., Ulianich, L., Chello, M. and Nappi, F. (2015). Basic and clinical research against advanced glycation end products (AGEs): new compounds to tackle cardiovascular disease and diabetic complications. Recent Advances in Cardiovascular Drug Discovery, 10, 10–33.
Payne, G. W. (2006). Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation, 13, 343–352.
Puyvelde, K., Van, Mets, T., Njemini, R., Beyer, I. and Bautmans, I. (2014). Effect of advanced glycation end product intake on inflammation and aging: a systematic review. Nutrition Reviews, 72, 638–650.
Rahmadi, A., Steiner, N. and Munch, G. (2011). Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC, 49, 385–391.
Ramakers, I. H. G. B.
et al. (2007). Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dementia and Geriatric Cognitive Disorders, 24, 300–306.
Reisberg, B., Ferris, S. H., de Leon, M. J. and Crook, T. (1982). The global deterioration scale for assessment of primary degenerative dementia. The American Journal of Psychiatry, 139, 1136–1139.
Ries, J. D., Echternach, J. L., Nof, L. and Gagnon Blodgett, M. (2009). Test-retest reliability and minimal detectable change scores for the timed “up & go” test, the six-minute walk test, and gait speed in people with Alzheimer disease. Physical Therapy, 89, 569–579.
Scherder, E., Eggermont, L., Visscher, C., Scheltens, P. and Swaab, D. (2011). Understanding higher level gait disturbances in mild dementia in order to improve rehabilitation: “last in-first out.” Neuroscience and Biobehavioral Reviews, 35, 699–714.
Sternberg, S. A., Wershof Schwartz, A., Karunananthan, S., Bergman, H. and Mark Clarfield, A. (2011). The identification of frailty: a systematic literature review. Journal of the American Geriatrics Society, 59, 2129–2138.
Whitson, H. E.
et al. (2014). Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 69, 710–716.